NVST peer analysis
Envista (NVST) against its competitors: price, today's move, 1-year return and market value side by side.
NVST and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ALHC Alignment Healthcare | $6.97 | -4.13% | -59.29% | – |
| CON Concentra | $40.33 | -0.12% | 100.85% | – |
| DYN Dyne Therapeutics | $17.30 | 3.68% | -26.52% | – |
| GRAL GRAIL | $133.60 | -6.85% | 56.79% | – |
| ICUI ICU Medical | $162.68 | -0.67% | 35.86% | $4.10B |
| PRVA Privia Health | $21.28 | -0.93% | -13.18% | – |
| RARE Ultragenyx | $16.32 | 1.37% | -53.60% | $1.59B |
| SUPN Supernus Pharmaceuticals | $41.92 | 0.19% | -25.81% | $2.44B |
| XRAY Dentsply Sirona | $9.89 | 3.78% | -21.45% | $1.90B |
| NVST Envista | $24.72 | 5.15% | 22.74% | $3.78B |
- NVST's peers: ALHC (Alignment Healthcare), CON (Concentra), DYN (Dyne Therapeutics), GRAL (GRAIL), ICUI (ICU Medical), PRVA (Privia Health), RARE (Ultragenyx), SUPN (Supernus Pharmaceuticals).
Updated 2026-11-03 00:46 UTC